Morusin, which separate from Mori cortex, was demonstrated effective anticancer activity by inhibiting the vitality of prostate cancer cells with minimal impact on normal prostate epithelial cells, reducing STAT3 activity via the inhibition of phosphorylation, nuclear accumulation and DNA-binding activity. The gene discussed is STAT3; the disease is prostate carcinoma.